Literature DB >> 30259283

Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty.

Ken Resnicow1, Minal R Patel2, M Chandler Mcleod3, Steven J Katz4,5, Reshma Jagsi6.   

Abstract

PURPOSE: High costs of cancer care place considerable burden on patients and society. Despite increasing recognition that providers should play a role in reducing care costs, how physicians across cancer specialties differ in their cost-consciousness has not been reported. We examined cost-consciousness regarding breast cancer care among medical oncologists, surgeons, and radiation oncologists.
METHODS: We identified 514 cancer surgeons, 504 medical oncologists, and 251 radiation oncologists by patient report through the iCanCare study. iCanCare identified newly diagnosed women with breast cancer through the Surveillance, Epidemiology, and End Results (SEER) registries of Georgia and Los Angeles. We queried providers on three dimensions of cost-consciousness: (1) perceived importance of cost saving for society, patients, practice, and payers; (2) awareness of patient out-of-pocket expenses; and (3) discussion of financial burden.
RESULTS: We received responses from 376 surgeons (73%), 304 medical oncologists (60%), and 169 radiation oncologists (67%). Overall levels of cost-consciousness were moderate, with scores ranging from 2.5 to 3.0 out of 5. After adjusting for covariates, surgeons had the lowest scores on all three cost-consciousness measures; medical oncologists had the highest scores. Pairwise contrasts showed surgeons had significantly lower scores than medical oncologists for all three measures and significantly lower scores than radiation oncologists for two of the three cost-consciousness variables: importance of cost saving and discussion of financial burden.
CONCLUSIONS: How cost-consciousness impacts medical decision-making across specialty and how policy, structural, and behavioral interventions might sensitize providers regarding cost-related matters merit further examination.

Entities:  

Keywords:  Cancer care costs; Cost-consciousness; Financial toxicity; Medical oncologists; Radiation oncologists; Surgeons

Mesh:

Year:  2018        PMID: 30259283      PMCID: PMC8968296          DOI: 10.1007/s10549-018-4976-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  19 in total

1.  The role of training environment care intensity in US physician cost consciousness.

Authors:  Kira L Ryskina; Scott D Halpern; Nancy S Minyanou; Susan D Goold; Jon C Tilburt
Journal:  Mayo Clin Proc       Date:  2015-01-26       Impact factor: 7.616

2.  Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.

Authors:  Scott R Berry; Chaim M Bell; Peter A Ubel; William K Evans; Eric Nadler; Elizabeth L Strevel; Peter J Neumann
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

3.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

4.  Do oncologists believe new cancer drugs offer good value?

Authors:  Eric Nadler; Ben Eckert; Peter J Neumann
Journal:  Oncologist       Date:  2006-02

5.  Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

Authors:  Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

6.  How Much Longer Will We Put Up With $100,000 Cancer Drugs?

Authors:  Paul Workman; Giulio F Draetta; Jan H M Schellens; René Bernards
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

7.  Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management.

Authors:  Monica Morrow; Paul Abrahamse; Timothy P Hofer; Kevin C Ward; Ann S Hamilton; Allison W Kurian; Steven J Katz; Reshma Jagsi
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

8.  Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?

Authors:  Steven J Katz; Sarah T Hawley; Irina Bondarenko; Reshma Jagsi; Kevin C Ward; Timothy P Hofer; Allison W Kurian
Journal:  Breast Cancer Res Treat       Date:  2017-07-08       Impact factor: 4.624

9.  Cancer drugs: high price, uncertain value.

Authors:  Deborah Cohen
Journal:  BMJ       Date:  2017-10-04

10.  Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.

Authors:  Steven J Katz; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Monica Morrow; Reshma Jagsi; Timothy P Hofer
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 16.681

View more
  6 in total

1.  Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.

Authors:  Fengrui Xu; Zefei Jiang
Journal:  Ann Transl Med       Date:  2020-02

2.  Perceived financial decline related to breast reconstruction following mastectomy in a diverse population-based cohort.

Authors:  Nicholas L Berlin; Paul Abrahamse; Adeyiza O Momoh; Steven J Katz; Reshma Jagsi; Ann S Hamilton; Kevin C Ward; Sarah T Hawley
Journal:  Cancer       Date:  2021-11-30       Impact factor: 6.860

3.  Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.

Authors:  Anupriya Agarwal; Deme J Karikios; Martin R Stockler; Rachael L Morton
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

4.  Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.

Authors:  K Robin Yabroff; Jingxuan Zhao; Janet S de Moor; Helmneh M Sineshaw; Andrew N Freedman; Zhiyuan Zheng; Xuesong Han; Ashish Rai; Carrie N Klabunde
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

Review 5.  A Scoping Review of Behavioral Interventions Addressing Medical Financial Hardship.

Authors:  Minal R Patel; Reshma Jagsi; Kenneth Resnicow; Shawna N Smith; Lauren M Hamel; Christopher Su; Jennifer J Griggs; Diamond Buchanan; Nicole Isaacson; Michelle Torby
Journal:  Popul Health Manag       Date:  2021-05-14       Impact factor: 2.459

6.  Voluntary or Forced: Different Effects of Personal and Social Norms on Urban Residents' Environmental Protection Behavior.

Authors:  Guanglin Bai; Yun Bai
Journal:  Int J Environ Res Public Health       Date:  2020-05-18       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.